by The global bioanalytical testing services market size accounted for US$ 10.39 Bn in 2022 and is projected to reach around USD 10.39 Bn by 2032, growing at a CAGR of 9.02% from 2023 to 2032.
Key Takeaways:
- North America generated more than 47% of revenue share in 2022.
- By Test Type, the bioavailability segment contributed to the largest revenue share in 2022.
- By Application, the oncology segment is expected to expand at the fastest CAGR between 2023 and 2032.
Report Summary
The global bioanalytical testing services market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the bioanalytical testing services market across the globe.
A comprehensive estimate on the bioanalytical testing services market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of bioanalytical testing services during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3107
Bioanalytical Testing Services Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 4.78 Billion |
| Market Size by 2032 | USD 10.39 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.02% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Test Type, By Molecules, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized bioanalytical testing services market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Therapeutic Respiratory Devices Market Size Analysis 2023 To 2032
Bioanalytical Testing Services Market Players
The report includes the profiles of key bioanalytical testing services market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- PPD, Inc.
- ICON Plc
- Charles River Laboratories International
- Covance, Inc.
- IQVIA
- Syneos Health
- SGS SA
- Toxikon
- Intertek Group Plc
- Pace Analytical Services LLC
Market Segmentation
By Test Type
- Pharmacokinetic
- Pharmacodynamics
- Bioavailability
- Bioequivalence
By Molecules
- Small Molecules
- Large Molecules
By Application
- Cardiology
- Gastroenterology
- Neurology
- Oncology
- Others
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations
- Contract Research Organizations
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioanalytical Testing Services Market
5.1. COVID-19 Landscape: Bioanalytical Testing Services Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioanalytical Testing Services Market, By Test Type
8.1. Bioanalytical Testing Services Market, by Test Type, 2023-2032
8.1.1. Pharmacokinetic
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Pharmacodynamics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Bioavailability
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Bioequivalence
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Bioanalytical Testing Services Market, By Molecules
9.1. Bioanalytical Testing Services Market, by Molecules, 2023-2032
9.1.1. Small Molecules
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Large Molecules
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Bioanalytical Testing Services Market, By Application
10.1. Bioanalytical Testing Services Market, by Application, 2023-2032
10.1.1. Cardiology
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Gastroenterology
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Neurology
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Oncology
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Bioanalytical Testing Services Market, By End User
11.1. Bioanalytical Testing Services Market, by End User, 2023-2032
11.1.1. Pharmaceutical and Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Contract Development and Manufacturing Organizations
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Bioanalytical Testing Services Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. PPD, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. ICON Plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Charles River Laboratories International
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Covance, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IQVIA
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Syneos Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. SGS SA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Toxikon
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Intertek Group Plc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Pace Analytical Services LLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
